Please assess the completion status of the following clinical trial:

Trial Title: MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subject has a diagnosis of Dupuytren's Disease affecting only the metacarpophalangeal joint of the 4th or 5th finger.~* Subject has only one finger affected by the disease.~* Patients will be 35 years of age of older.~* Patients will be able to read, speak, and understand English or have available adequate translation assistance and be able to provide voluntary written consent to participate.~Exclusion Criteria:~* Female patients who are nursing or pregnant, or plan to become pregnant during the treatment phase.~* Patient has a chronic muscular, neurological or neuromuscular disorder that affects the hands.~* Patient has known allergy to collagenase or any other excipient of Xiaflex.~* Patient has received any collagenase treatments before the first dose of Xiaflex.~* Patient with abnormal coagulation, including patients who have received anticoagulant medications other than low-dose aspirin within 7 days of the injection.

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- XIAFLEX (Type: OTHER): XIAFlEX

Based on this trial design, predict the completion outcome and termination type (if applicable).